| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 EP300 | 1.70e-15 | 303 | 27 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SS18 SF1 EP300 | 8.48e-14 | 562 | 27 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SNAP91 SS18 SF1 EP300 ITSN2 | 2.23e-11 | 1356 | 27 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A KAT6B SNAP91 SS18 SF1 EP300 | 4.54e-11 | 1160 | 27 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.78e-10 | 61 | 27 | 6 | GO:0030374 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.28e-09 | 187 | 27 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 8.38e-09 | 53 | 27 | 5 | GO:0030331 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.16e-08 | 739 | 27 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.34e-07 | 51 | 27 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.62e-07 | 55 | 27 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.02e-06 | 417 | 27 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.23e-06 | 60 | 27 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.48e-06 | 20 | 27 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.88e-06 | 21 | 27 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.53e-06 | 78 | 27 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.83e-06 | 23 | 27 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 9.21e-06 | 582 | 27 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.03e-05 | 102 | 27 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.11e-05 | 104 | 27 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.28e-05 | 34 | 27 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.96e-05 | 120 | 27 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.84e-05 | 753 | 27 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 5.52e-05 | 55 | 27 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | clathrin binding | 8.29e-05 | 63 | 27 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.83e-04 | 15 | 27 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.40e-04 | 229 | 27 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.78e-04 | 238 | 27 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 9.06e-04 | 33 | 27 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 9.34e-04 | 875 | 27 | 6 | GO:0019904 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.65e-03 | 1459 | 27 | 7 | GO:0000977 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 3.45e-03 | 775 | 27 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | p53 binding | 4.84e-03 | 77 | 27 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.60e-03 | 83 | 27 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 5.73e-03 | 84 | 27 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | SMAD binding | 6.00e-03 | 86 | 27 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 6.43e-03 | 560 | 27 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 6.68e-03 | 566 | 27 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.53e-02 | 140 | 27 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.39e-02 | 1244 | 27 | 5 | GO:0000978 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 KAT6B SS18 LEF1 EP300 TP63 MEIS1 | 1.67e-10 | 1390 | 26 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 4.37e-09 | 202 | 26 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 1.52e-08 | 136 | 26 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.62e-08 | 244 | 26 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.32e-08 | 155 | 26 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 3.38e-07 | 381 | 26 | 7 | GO:0048545 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.10e-07 | 237 | 26 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 4.31e-07 | 239 | 26 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.64e-07 | 242 | 26 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 4.76e-07 | 51 | 26 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 6.07e-07 | 1141 | 26 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 6.10e-07 | 416 | 26 | 7 | GO:0030522 | |
| GeneOntologyBiologicalProcess | labyrinthine layer development | 1.20e-06 | 64 | 26 | 4 | GO:0060711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.66e-06 | 78 | 26 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 3.46e-06 | 540 | 26 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.11e-06 | 87 | 26 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | placenta development | 4.22e-06 | 197 | 26 | 5 | GO:0001890 | |
| GeneOntologyBiologicalProcess | embryo development | 4.93e-06 | 1437 | 26 | 10 | GO:0009790 | |
| GeneOntologyBiologicalProcess | labyrinthine layer morphogenesis | 5.70e-06 | 28 | 26 | 3 | GO:0060713 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 9.15e-06 | 4 | 26 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 9.15e-06 | 4 | 26 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | embryonic placenta morphogenesis | 9.46e-06 | 33 | 26 | 3 | GO:0060669 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.04e-05 | 906 | 26 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 1.10e-05 | 1223 | 26 | 9 | GO:0030097 | |
| GeneOntologyBiologicalProcess | head development | 1.15e-05 | 919 | 26 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.24e-05 | 929 | 26 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | embryonic placenta development | 1.43e-05 | 119 | 26 | 4 | GO:0001892 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 2.28e-05 | 6 | 26 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 2.40e-05 | 727 | 26 | 7 | GO:0032870 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.72e-05 | 741 | 26 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | response to hormone | 2.85e-05 | 1042 | 26 | 8 | GO:0009725 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 2.96e-05 | 48 | 26 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 3.02e-05 | 144 | 26 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 3.56e-05 | 51 | 26 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | clathrin-dependent endocytosis | 3.99e-05 | 53 | 26 | 3 | GO:0072583 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 4.07e-05 | 1095 | 26 | 8 | GO:0060284 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.79e-05 | 162 | 26 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 4.97e-05 | 57 | 26 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 5.47e-05 | 9 | 26 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 5.54e-05 | 558 | 26 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | brain development | 6.96e-05 | 859 | 26 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 7.04e-05 | 64 | 26 | 3 | GO:0010171 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 8.67e-05 | 605 | 26 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | chromatin organization | 9.08e-05 | 896 | 26 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | female mating behavior | 1.00e-04 | 12 | 26 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | positive regulation of adipose tissue development | 1.38e-04 | 14 | 26 | 2 | GO:1904179 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.74e-04 | 226 | 26 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.79e-04 | 999 | 26 | 7 | GO:0071824 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 2.05e-04 | 17 | 26 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 2.05e-04 | 17 | 26 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 2.07e-04 | 445 | 26 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 2.26e-04 | 242 | 26 | 4 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 2.26e-04 | 242 | 26 | 4 | GO:1903708 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.27e-04 | 1399 | 26 | 8 | GO:0045892 | |
| GeneOntologyBiologicalProcess | tube development | 2.31e-04 | 1402 | 26 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 2.31e-04 | 18 | 26 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 2.31e-04 | 18 | 26 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.40e-04 | 1048 | 26 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.44e-04 | 1413 | 26 | 8 | GO:1902679 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 2.76e-04 | 748 | 26 | 6 | GO:0071396 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.99e-04 | 482 | 26 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of clathrin-dependent endocytosis | 3.16e-04 | 21 | 26 | 2 | GO:2000369 | |
| GeneOntologyBiologicalProcess | regulation of adipose tissue development | 3.16e-04 | 21 | 26 | 2 | GO:1904177 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.23e-04 | 266 | 26 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 3.32e-04 | 108 | 26 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.72e-04 | 276 | 26 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | response to lipid | 3.73e-04 | 1126 | 26 | 7 | GO:0033993 | |
| GeneOntologyBiologicalProcess | clathrin coat assembly | 3.80e-04 | 23 | 26 | 2 | GO:0048268 | |
| GeneOntologyBiologicalProcess | pattern specification process | 4.47e-04 | 526 | 26 | 5 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.48e-04 | 290 | 26 | 4 | GO:0050870 | |
| GeneOntologyBiologicalProcess | megakaryocyte development | 4.87e-04 | 26 | 26 | 2 | GO:0035855 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.32e-04 | 1194 | 26 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | central nervous system development | 5.40e-04 | 1197 | 26 | 7 | GO:0007417 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.46e-04 | 850 | 26 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | peroxisome proliferator activated receptor signaling pathway | 5.66e-04 | 28 | 26 | 2 | GO:0035357 | |
| GeneOntologyBiologicalProcess | muscle structure development | 5.73e-04 | 858 | 26 | 6 | GO:0061061 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 5.85e-04 | 558 | 26 | 5 | GO:0030099 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 5.99e-04 | 561 | 26 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 6.27e-04 | 317 | 26 | 4 | GO:1903039 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 6.52e-04 | 136 | 26 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | response to growth factor | 6.67e-04 | 883 | 26 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 7.66e-04 | 1269 | 26 | 7 | GO:0009887 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 7.79e-04 | 336 | 26 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | developmental growth | 7.86e-04 | 911 | 26 | 6 | GO:0048589 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 7.87e-04 | 596 | 26 | 5 | GO:0001701 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 8.41e-04 | 343 | 26 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 8.97e-04 | 349 | 26 | 4 | GO:0014706 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 9.00e-04 | 614 | 26 | 5 | GO:0010720 | |
| GeneOntologyBiologicalProcess | sex differentiation | 9.26e-04 | 352 | 26 | 4 | GO:0007548 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 9.38e-04 | 36 | 26 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | mesoderm development | 9.89e-04 | 157 | 26 | 3 | GO:0007498 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.01e-03 | 360 | 26 | 4 | GO:0048511 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.08e-03 | 162 | 26 | 3 | GO:0030879 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte differentiation | 1.16e-03 | 40 | 26 | 2 | GO:0045616 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.22e-03 | 41 | 26 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.25e-03 | 382 | 26 | 4 | GO:0030217 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.79e-09 | 596 | 27 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 CSTF2 NCOA1 BCL9L NCOA3 NCOA6 BCL9 ARID1A SS18 LEF1 PRPF40A NUP210L SF1 | 3.49e-09 | 1377 | 27 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 5.45e-07 | 13 | 27 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | chromatin | NCOA2 NCOA1 NCOA3 ZMIZ1 ARID1A KAT6B SS18 LEF1 EP300 TP63 MEIS1 | 9.76e-07 | 1480 | 27 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.08e-06 | 272 | 27 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 1.57e-05 | 38 | 27 | 3 | GO:0030125 | |
| GeneOntologyCellularComponent | clathrin coat | 5.09e-05 | 56 | 27 | 3 | GO:0030118 | |
| GeneOntologyCellularComponent | vesicle coat | 8.71e-05 | 67 | 27 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | npBAF complex | 1.45e-04 | 14 | 27 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | membrane coat | 3.39e-04 | 106 | 27 | 3 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 3.39e-04 | 106 | 27 | 3 | GO:0048475 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.83e-04 | 30 | 27 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 7.30e-04 | 31 | 27 | 2 | GO:0030131 | |
| GeneOntologyCellularComponent | nuclear body | 8.67e-04 | 903 | 27 | 6 | GO:0016604 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 8.81e-04 | 147 | 27 | 3 | GO:0030665 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 1.75e-03 | 48 | 27 | 2 | GO:0030119 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.62e-03 | 215 | 27 | 3 | GO:0030662 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 3.44e-03 | 237 | 27 | 3 | GO:0030136 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.53e-03 | 94 | 27 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 6.80e-03 | 96 | 27 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 7.93e-03 | 104 | 27 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 8.69e-03 | 109 | 27 | 2 | GO:1902493 | |
| GeneOntologyCellularComponent | coated vesicle | 1.09e-02 | 360 | 27 | 3 | GO:0030135 | |
| GeneOntologyCellularComponent | ATPase complex | 1.20e-02 | 129 | 27 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.40e-02 | 140 | 27 | 2 | GO:0016363 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.42e-02 | 141 | 27 | 2 | GO:0048786 | |
| HumanPheno | Hypospadias | 1.22e-05 | 377 | 6 | 5 | HP:0000047 | |
| HumanPheno | Patent ductus arteriosus | 1.30e-05 | 382 | 6 | 5 | HP:0001643 | |
| HumanPheno | Displacement of the urethral meatus | 1.58e-05 | 397 | 6 | 5 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 1.62e-05 | 399 | 6 | 5 | HP:0032076 | |
| HumanPheno | Brachydactyly (hand) | 2.34e-05 | 430 | 6 | 5 | HP:0100667 | |
| HumanPheno | Abnormality of the urethra | 3.45e-05 | 465 | 6 | 5 | HP:0000795 | |
| HumanPheno | Abnormal hallux morphology | 4.10e-05 | 212 | 6 | 4 | HP:0001844 | |
| HumanPheno | Congenital malformation of the great arteries | 6.51e-05 | 529 | 6 | 5 | HP:0011603 | |
| HumanPheno | Abnormality of dental eruption | 6.69e-05 | 240 | 6 | 4 | HP:0006292 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 7.08e-05 | 538 | 6 | 5 | HP:0005927 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 9.28e-05 | 87 | 6 | 3 | HP:0000614 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 9.57e-05 | 572 | 6 | 5 | HP:0006496 | |
| HumanPheno | Deviation of the hallux | 9.60e-05 | 88 | 6 | 3 | HP:0010051 | |
| HumanPheno | Delayed speech and language development | 1.14e-04 | 1123 | 6 | 6 | HP:0000750 | |
| HumanPheno | Language impairment | 1.51e-04 | 1178 | 6 | 6 | HP:0002463 | |
| HumanPheno | Facial hirsutism | 1.75e-04 | 18 | 6 | 2 | HP:0009937 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 2.05e-04 | 319 | 6 | 4 | HP:0009767 | |
| HumanPheno | Brachydactyly | 2.08e-04 | 670 | 6 | 5 | HP:0001156 | |
| HumanPheno | Short digit | 2.11e-04 | 672 | 6 | 5 | HP:0011927 | |
| HumanPheno | Abnormal nasal septum morphology | 2.13e-04 | 115 | 6 | 3 | HP:0000419 | |
| HumanPheno | Deviation of toes | 2.30e-04 | 118 | 6 | 3 | HP:0100498 | |
| HumanPheno | Localized hirsutism | 2.40e-04 | 21 | 6 | 2 | HP:0009889 | |
| HumanPheno | Abnormal penis morphology | 2.80e-04 | 712 | 6 | 5 | HP:0000036 | |
| HumanPheno | Blepharophimosis | 3.00e-04 | 129 | 6 | 3 | HP:0000581 | |
| HumanPheno | Abnormal morphology of the great vessels | 3.29e-04 | 736 | 6 | 5 | HP:0030962 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 3.50e-04 | 366 | 6 | 4 | HP:0006265 | |
| HumanPheno | Aplasia involving bones of the extremities | 3.82e-04 | 759 | 6 | 5 | HP:0009825 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 3.87e-04 | 761 | 6 | 5 | HP:0045060 | |
| HumanPheno | Thin hair | 4.07e-04 | 143 | 6 | 3 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 4.07e-04 | 143 | 6 | 3 | HP:0002209 | |
| HumanPheno | Thin scalp hair | 4.07e-04 | 143 | 6 | 3 | HP:0002556 | |
| HumanPheno | Cryptorchidism | 4.36e-04 | 780 | 6 | 5 | HP:0000028 | |
| HumanPheno | Thick eyebrow | 5.07e-04 | 154 | 6 | 3 | HP:0000574 | |
| HumanPheno | Abnormality of tear glands or tear production | 5.27e-04 | 156 | 6 | 3 | HP:0000521 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 5.34e-04 | 813 | 6 | 5 | HP:0009815 | |
| HumanPheno | Intestinal malrotation | 5.37e-04 | 157 | 6 | 3 | HP:0002566 | |
| HumanPheno | Abnormality of mouth size | 6.26e-04 | 425 | 6 | 4 | HP:0011337 | |
| HumanPheno | Anal stenosis | 6.38e-04 | 34 | 6 | 2 | HP:0002025 | |
| HumanPheno | Abnormality of the scalp hair | 6.73e-04 | 433 | 6 | 4 | HP:0100037 | |
| HumanPheno | Abnormal number of permanent teeth | 6.76e-04 | 35 | 6 | 2 | HP:0011044 | |
| HumanPheno | Disturbance of facial expression | 7.16e-04 | 36 | 6 | 2 | HP:0005324 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 7.16e-04 | 36 | 6 | 2 | HP:0010173 | |
| HumanPheno | Nasolacrimal duct obstruction | 7.16e-04 | 36 | 6 | 2 | HP:0000579 | |
| HumanPheno | Nasogastric tube feeding in infancy | 7.56e-04 | 37 | 6 | 2 | HP:0011470 | |
| HumanPheno | Abnormal scalp morphology | 7.81e-04 | 450 | 6 | 4 | HP:0001965 | |
| HumanPheno | Abnormal toe morphology | 8.41e-04 | 893 | 6 | 5 | HP:0001780 | |
| HumanPheno | Abnormality of the helix | 8.42e-04 | 183 | 6 | 3 | HP:0000380 | |
| HumanPheno | Abnormality of upper lip vermillion | 8.78e-04 | 464 | 6 | 4 | HP:0011339 | |
| HumanPheno | Abnormal external nose morphology | 9.51e-04 | 916 | 6 | 5 | HP:0010938 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 9.54e-04 | 474 | 6 | 4 | HP:0006493 | |
| HumanPheno | Gray matter heterotopias | 9.75e-04 | 42 | 6 | 2 | HP:0002281 | |
| HumanPheno | Periventricular heterotopia | 9.75e-04 | 42 | 6 | 2 | HP:0007165 | |
| HumanPheno | Abnormality of the lower urinary tract | 1.06e-03 | 937 | 6 | 5 | HP:0010936 | |
| HumanPheno | Wide nasal bridge | 1.24e-03 | 508 | 6 | 4 | HP:0000431 | |
| HumanPheno | Abnormal 5th finger morphology | 1.25e-03 | 509 | 6 | 4 | HP:0004207 | |
| HumanPheno | Ventricular septal defect | 1.26e-03 | 510 | 6 | 4 | HP:0001629 | |
| HumanPheno | Abnormal helix morphology | 1.30e-03 | 212 | 6 | 3 | HP:0011039 | |
| HumanPheno | Abnormal upper lip morphology | 1.32e-03 | 980 | 6 | 5 | HP:0000177 | |
| HumanPheno | Feeding difficulties | 1.33e-03 | 982 | 6 | 5 | HP:0002022 | |
| HumanPheno | Hirsutism | 1.37e-03 | 216 | 6 | 3 | HP:0001007 | |
| HumanPheno | Abnormal ventricular septum morphology | 1.37e-03 | 521 | 6 | 4 | HP:0010438 | |
| HumanPheno | Cutaneous syndactyly of toes | 1.38e-03 | 50 | 6 | 2 | HP:0010621 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.38e-03 | 50 | 6 | 2 | HP:0011481 | |
| HumanPheno | Vesicoureteral reflux | 1.46e-03 | 221 | 6 | 3 | HP:0000076 | |
| HumanPheno | Abnormal nasal bridge morphology | 1.67e-03 | 1029 | 6 | 5 | HP:0000422 | |
| HumanPheno | Narrow mouth | 1.73e-03 | 234 | 6 | 3 | HP:0000160 | |
| HumanPheno | Low hanging columella | 1.73e-03 | 56 | 6 | 2 | HP:0009765 | |
| HumanPheno | Joint hypermobility | 1.77e-03 | 557 | 6 | 4 | HP:0001382 | |
| HumanPheno | Prominent nasal bridge | 1.84e-03 | 239 | 6 | 3 | HP:0000426 | |
| HumanPheno | Toe syndactyly | 1.95e-03 | 244 | 6 | 3 | HP:0001770 | |
| HumanPheno | Abnormal ureter physiology | 1.97e-03 | 245 | 6 | 3 | HP:0025634 | |
| HumanPheno | Clinodactyly | 1.99e-03 | 574 | 6 | 4 | HP:0030084 | |
| HumanPheno | Abnormal nasopharynx morphology | 2.07e-03 | 249 | 6 | 3 | HP:0001739 | |
| HumanPheno | Abnormal incisor morphology | 2.12e-03 | 62 | 6 | 2 | HP:0011063 | |
| HumanPheno | Abnormal hand morphology | 2.12e-03 | 1082 | 6 | 5 | HP:0005922 | |
| HumanPheno | Hypoplastic ilia | 2.19e-03 | 63 | 6 | 2 | HP:0000946 | |
| HumanPheno | Labial hypoplasia | 2.26e-03 | 64 | 6 | 2 | HP:0000066 | |
| HumanPheno | Feeding difficulties in infancy | 2.26e-03 | 594 | 6 | 4 | HP:0008872 | |
| HumanPheno | Abnormal pharynx morphology | 2.34e-03 | 260 | 6 | 3 | HP:0033151 | |
| HumanPheno | Aplasia/Hypoplasia of metatarsal bones | 2.40e-03 | 66 | 6 | 2 | HP:0001964 | |
| HumanPheno | Anonychia | 2.40e-03 | 66 | 6 | 2 | HP:0001798 | |
| HumanPheno | Hydronephrosis | 2.45e-03 | 264 | 6 | 3 | HP:0000126 | |
| HumanPheno | Depressed nasal bridge | 2.54e-03 | 612 | 6 | 4 | HP:0005280 | |
| HumanPheno | Flattened nasal bridge | 2.54e-03 | 612 | 6 | 4 | HP:0000425 | |
| HumanPheno | Hypoplastic female external genitalia | 2.54e-03 | 68 | 6 | 2 | HP:0012815 | |
| HumanPheno | Anteriorly placed anus | 2.54e-03 | 68 | 6 | 2 | HP:0001545 | |
| MousePheno | decreased hair follicle number | 6.52e-05 | 41 | 27 | 3 | MP:0000379 | |
| MousePheno | abnormal mammary gland number | 7.50e-05 | 7 | 27 | 2 | MP:0013714 | |
| MousePheno | decreased mammary gland number | 7.50e-05 | 7 | 27 | 2 | MP:0013715 | |
| MousePheno | absent mammary gland | 7.50e-05 | 7 | 27 | 2 | MP:0000629 | |
| MousePheno | abnormal vagina epithelium morphology | 1.28e-04 | 9 | 27 | 2 | MP:0001140 | |
| MousePheno | abnormal prenatal body size | 1.60e-04 | 1116 | 27 | 9 | MP:0010866 | |
| MousePheno | embryonic lethality during organogenesis | 1.75e-04 | 876 | 27 | 8 | MP:0006207 | |
| MousePheno | kinked neural tube | 1.75e-04 | 57 | 27 | 3 | MP:0003400 | |
| MousePheno | decreased embryo size | 1.95e-04 | 659 | 27 | 7 | MP:0001698 | |
| MousePheno | abnormal extraembryonic tissue morphology | 2.25e-04 | 908 | 27 | 8 | MP:0002086 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 2.82e-04 | 700 | 27 | 7 | MP:0011098 | |
| MousePheno | abnormal prenatal growth/weight/body size | 2.86e-04 | 1493 | 27 | 10 | MP:0004196 | |
| MousePheno | abnormal embryo size | 3.20e-04 | 956 | 27 | 8 | MP:0001697 | |
| MousePheno | abnormal skin adnexa development | 3.47e-04 | 177 | 27 | 4 | MP:0020982 | |
| MousePheno | abnormal chorionic plate morphology | 3.71e-04 | 15 | 27 | 2 | MP:0004560 | |
| MousePheno | abnormal epicardium morphology | 4.80e-04 | 17 | 27 | 2 | MP:0003057 | |
| MousePheno | abnormal vascular development | 4.88e-04 | 542 | 27 | 6 | MP:0000259 | |
| MousePheno | abnormal embryonic growth/weight/body size | 4.90e-04 | 1295 | 27 | 9 | MP:0002088 | |
| MousePheno | abnormal mammary gland morphology | 5.62e-04 | 201 | 27 | 4 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 5.62e-04 | 201 | 27 | 4 | MP:0013554 | |
| MousePheno | abnormal megakaryocyte morphology | 5.91e-04 | 86 | 27 | 3 | MP:0002417 | |
| MousePheno | absent teeth | 6.68e-04 | 20 | 27 | 2 | MP:0030610 | |
| MousePheno | craniofacial phenotype | 7.50e-04 | 1372 | 27 | 9 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 7.50e-04 | 1372 | 27 | 9 | MP:0000428 | |
| MousePheno | abnormal lacrimal apparatus morphology | 8.10e-04 | 22 | 27 | 2 | MP:0008968 | |
| MousePheno | absent myocardial trabeculae | 8.10e-04 | 22 | 27 | 2 | MP:0000293 | |
| MousePheno | abnormal bone marrow hematopoietic cell morphology | 9.71e-04 | 102 | 27 | 3 | MP:0013660 | |
| MousePheno | abnormal gland development | 9.76e-04 | 233 | 27 | 4 | MP:0020973 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.00e-03 | 410 | 27 | 5 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.00e-03 | 410 | 27 | 5 | MP:0011102 | |
| MousePheno | pale yolk sac | 1.21e-03 | 110 | 27 | 3 | MP:0001722 | |
| MousePheno | pericardial effusion | 1.24e-03 | 111 | 27 | 3 | MP:0005312 | |
| MousePheno | hyperactivity | 1.25e-03 | 1172 | 27 | 8 | MP:0001399 | |
| MousePheno | abnormal spongiotrophoblast size | 1.32e-03 | 28 | 27 | 2 | MP:0012097 | |
| MousePheno | abnormal ear position | 1.32e-03 | 28 | 27 | 2 | MP:0000023 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 1.64e-03 | 268 | 27 | 4 | MP:0011108 | |
| MousePheno | abnormal mammary gland development | 1.79e-03 | 126 | 27 | 3 | MP:0000628 | |
| MousePheno | abnormal gastrulation | 1.82e-03 | 469 | 27 | 5 | MP:0001695 | |
| MousePheno | abnormal vascular branching morphogenesis | 1.83e-03 | 33 | 27 | 2 | MP:0003227 | |
| MousePheno | increased startle reflex | 1.95e-03 | 281 | 27 | 4 | MP:0001488 | |
| MousePheno | abnormal nervous system development | 1.96e-03 | 1257 | 27 | 8 | MP:0003861 | |
| Domain | Nuc_rcpt_coact | 5.18e-11 | 6 | 27 | 4 | IPR009110 | |
| Domain | DUF1518 | 2.69e-09 | 3 | 27 | 3 | PF07469 | |
| Domain | DUF1518 | 2.69e-09 | 3 | 27 | 3 | IPR010011 | |
| Domain | Src1_rcpt_coact | 2.69e-09 | 3 | 27 | 3 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 2.69e-09 | 3 | 27 | 3 | IPR017426 | |
| Domain | DUF1518 | 2.69e-09 | 3 | 27 | 3 | SM01151 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 2.69e-09 | 3 | 27 | 3 | IPR014920 | |
| Domain | SRC-1 | 2.69e-09 | 3 | 27 | 3 | IPR014935 | |
| Domain | SRC-1 | 2.69e-09 | 3 | 27 | 3 | PF08832 | |
| Domain | - | 2.69e-09 | 3 | 27 | 3 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 2.69e-09 | 3 | 27 | 3 | PF08815 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.01e-06 | 2 | 27 | 2 | IPR024670 | |
| Domain | BCL9 | 2.01e-06 | 2 | 27 | 2 | PF11502 | |
| Domain | DUF4927 | 2.01e-06 | 2 | 27 | 2 | PF16279 | |
| Domain | DUF4927 | 2.01e-06 | 2 | 27 | 2 | IPR032565 | |
| Domain | Bcl-9 | 2.01e-06 | 2 | 27 | 2 | IPR015668 | |
| Domain | PAS | 6.07e-06 | 25 | 27 | 3 | PF00989 | |
| Domain | PAS_fold | 6.07e-06 | 25 | 27 | 3 | IPR013767 | |
| Domain | PAS | 1.30e-05 | 32 | 27 | 3 | SM00091 | |
| Domain | PAS | 1.56e-05 | 34 | 27 | 3 | IPR000014 | |
| Domain | PAS | 1.56e-05 | 34 | 27 | 3 | PS50112 | |
| Domain | ENTH | 7.20e-05 | 9 | 27 | 2 | PS50942 | |
| Domain | ENTH | 7.20e-05 | 9 | 27 | 2 | SM00273 | |
| Domain | ENTH | 8.99e-05 | 10 | 27 | 2 | IPR013809 | |
| Domain | EH | 1.10e-04 | 11 | 27 | 2 | PS50031 | |
| Domain | EH | 1.10e-04 | 11 | 27 | 2 | SM00027 | |
| Domain | EH_dom | 1.10e-04 | 11 | 27 | 2 | IPR000261 | |
| Domain | - | 5.11e-04 | 109 | 27 | 3 | 4.10.280.10 | |
| Domain | HLH | 6.12e-04 | 116 | 27 | 3 | SM00353 | |
| Domain | BHLH | 6.28e-04 | 117 | 27 | 3 | PS50888 | |
| Domain | - | 6.40e-04 | 26 | 27 | 2 | 1.25.40.90 | |
| Domain | bHLH_dom | 6.44e-04 | 118 | 27 | 3 | IPR011598 | |
| Domain | ArfGap | 7.98e-04 | 29 | 27 | 2 | SM00105 | |
| Domain | ENTH_VHS | 7.98e-04 | 29 | 27 | 2 | IPR008942 | |
| Domain | ARFGAP | 7.98e-04 | 29 | 27 | 2 | PS50115 | |
| Domain | ArfGAP | 7.98e-04 | 29 | 27 | 2 | IPR001164 | |
| Domain | ArfGap | 7.98e-04 | 29 | 27 | 2 | PF01412 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.95e-08 | 18 | 24 | 4 | M26942 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.42e-08 | 26 | 24 | 4 | MM14793 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.72e-07 | 30 | 24 | 4 | M207 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.59e-07 | 84 | 24 | 5 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.87e-07 | 91 | 24 | 5 | M39700 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 7.09e-07 | 11 | 24 | 3 | M47503 | |
| Pathway | REACTOME_ADIPOGENESIS | 9.97e-07 | 110 | 24 | 5 | M48259 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.30e-06 | 49 | 24 | 4 | M41832 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.41e-06 | 118 | 24 | 5 | M27316 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.95e-06 | 15 | 24 | 3 | M119 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 3.83e-06 | 64 | 24 | 4 | M200 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 5.50e-06 | 70 | 24 | 4 | M938 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.54e-06 | 22 | 24 | 3 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.57e-06 | 24 | 24 | 3 | M13404 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 9.37e-06 | 80 | 24 | 4 | M223 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.23e-05 | 27 | 24 | 3 | M26943 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.56e-05 | 91 | 24 | 4 | M27101 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.89e-05 | 31 | 24 | 3 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.08e-05 | 32 | 24 | 3 | M39567 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 2.77e-05 | 5 | 24 | 2 | M48983 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 4.77e-05 | 42 | 24 | 3 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 4.77e-05 | 42 | 24 | 3 | M27272 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 4.77e-05 | 42 | 24 | 3 | M27172 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 4.96e-05 | 122 | 24 | 4 | M29689 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.49e-05 | 44 | 24 | 3 | M27295 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.84e-05 | 1432 | 24 | 10 | M509 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 6.27e-05 | 46 | 24 | 3 | MM14935 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.73e-05 | 8 | 24 | 2 | M22058 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 8.11e-05 | 272 | 24 | 5 | M29619 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 8.97e-05 | 142 | 24 | 4 | M27233 | |
| Pathway | PID_AR_TF_PATHWAY | 9.61e-05 | 53 | 24 | 3 | M151 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.07e-04 | 55 | 24 | 3 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.07e-04 | 55 | 24 | 3 | M27001 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.08e-04 | 149 | 24 | 4 | M27888 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.36e-04 | 158 | 24 | 4 | MM14791 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.39e-04 | 60 | 24 | 3 | M41830 | |
| Pathway | PID_AR_PATHWAY | 1.46e-04 | 61 | 24 | 3 | M58 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.59e-04 | 314 | 24 | 5 | M39428 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.61e-04 | 63 | 24 | 3 | MM15613 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.85e-04 | 66 | 24 | 3 | M255 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.01e-04 | 175 | 24 | 4 | MM14941 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.14e-04 | 13 | 24 | 2 | MM15622 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.50e-04 | 14 | 24 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 2.50e-04 | 14 | 24 | 2 | MM14748 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.88e-04 | 15 | 24 | 2 | MM1439 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M8516 | |
| Pathway | PID_REG_GR_PATHWAY | 3.52e-04 | 82 | 24 | 3 | M115 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 3.52e-04 | 82 | 24 | 3 | M2 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 4.02e-04 | 210 | 24 | 4 | M41836 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 4.18e-04 | 18 | 24 | 2 | M4862 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 4.18e-04 | 18 | 24 | 2 | MM15034 | |
| Pathway | WNT_SIGNALING | 4.47e-04 | 89 | 24 | 3 | M5493 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 4.67e-04 | 19 | 24 | 2 | MM14612 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 4.80e-04 | 220 | 24 | 4 | M27794 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 5.42e-04 | 95 | 24 | 3 | M48268 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 5.58e-04 | 96 | 24 | 3 | M26973 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 5.96e-04 | 233 | 24 | 4 | M27099 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.56e-04 | 239 | 24 | 4 | MM14756 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.88e-04 | 23 | 24 | 2 | M1926 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.88e-04 | 23 | 24 | 2 | MM14741 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 8.14e-04 | 25 | 24 | 2 | M11184 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 8.23e-04 | 254 | 24 | 4 | M27131 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 8.30e-04 | 110 | 24 | 3 | MM15977 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 8.81e-04 | 26 | 24 | 2 | M39407 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 9.50e-04 | 27 | 24 | 2 | MM14844 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.10e-03 | 29 | 24 | 2 | M48076 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 1.34e-03 | 32 | 24 | 2 | M40041 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.42e-03 | 33 | 24 | 2 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.42e-03 | 33 | 24 | 2 | MM14737 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.44e-03 | 133 | 24 | 3 | MM15529 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.45e-03 | 296 | 24 | 4 | M27869 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.51e-03 | 34 | 24 | 2 | MM15531 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.54e-03 | 301 | 24 | 4 | MM15983 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.57e-03 | 137 | 24 | 3 | M48232 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.78e-03 | 37 | 24 | 2 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.78e-03 | 37 | 24 | 2 | M29790 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.08e-03 | 40 | 24 | 2 | MM15000 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.16e-03 | 330 | 24 | 4 | M7847 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.19e-03 | 154 | 24 | 3 | M27832 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.19e-03 | 154 | 24 | 3 | M39739 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.52e-03 | 44 | 24 | 2 | M499 | |
| Pathway | PID_HNF3A_PATHWAY | 2.52e-03 | 44 | 24 | 2 | M285 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 2.53e-03 | 162 | 24 | 3 | MM15688 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 2.63e-03 | 45 | 24 | 2 | M39615 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.63e-03 | 45 | 24 | 2 | MM14751 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.87e-03 | 47 | 24 | 2 | M29777 | |
| Pathway | WP_ENERGY_METABOLISM | 2.99e-03 | 48 | 24 | 2 | M39590 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.99e-03 | 48 | 24 | 2 | M288 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 3.37e-03 | 51 | 24 | 2 | M39721 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 3.50e-03 | 52 | 24 | 2 | MM15684 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 3.50e-03 | 52 | 24 | 2 | M2404 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 3.63e-03 | 53 | 24 | 2 | MM15880 | |
| Pathway | PID_TAP63_PATHWAY | 3.77e-03 | 54 | 24 | 2 | M256 | |
| Pathway | REACTOME_SUMOYLATION | 3.90e-03 | 189 | 24 | 3 | M27214 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 3.90e-03 | 55 | 24 | 2 | M39351 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 4.02e-03 | 191 | 24 | 3 | MM15586 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.48e-03 | 59 | 24 | 2 | M39886 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 4.63e-03 | 201 | 24 | 3 | M39605 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.25e-03 | 64 | 24 | 2 | M5650 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.41e-03 | 65 | 24 | 2 | M39682 | |
| Pubmed | 2.01e-15 | 152 | 27 | 9 | 38360978 | ||
| Pubmed | 2.91e-13 | 83 | 27 | 7 | 28794006 | ||
| Pubmed | NCOA2 CSTF2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 SMAP2 PRPF40A EP300 | 4.46e-13 | 1429 | 27 | 14 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 ARID1A PSPC1 PRPF40A EP300 | 9.61e-13 | 457 | 27 | 10 | 32344865 |
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 12714702 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 1.44e-12 | 5 | 27 | 4 | 9812974 | |
| Pubmed | 2.93e-12 | 20 | 27 | 5 | 11877444 | ||
| Pubmed | 3.84e-12 | 21 | 27 | 5 | 19596656 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.92e-12 | 351 | 27 | 9 | 38297188 | |
| Pubmed | 4.31e-12 | 6 | 27 | 4 | 16923966 | ||
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 12709428 | ||
| Pubmed | 2.01e-11 | 8 | 27 | 4 | 12082103 | ||
| Pubmed | 2.15e-11 | 425 | 27 | 9 | 24999758 | ||
| Pubmed | 9.47e-11 | 11 | 27 | 4 | 36613751 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 2.87e-10 | 14 | 27 | 4 | 11500849 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.94e-10 | 220 | 27 | 7 | 35785414 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 21035760 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 21059860 | ||
| Pubmed | Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. | 4.17e-10 | 3 | 27 | 3 | 16675958 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 9506940 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 28390937 | ||
| Pubmed | Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. | 4.17e-10 | 3 | 27 | 3 | 23927929 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 33574497 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 18845648 | ||
| Pubmed | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | 4.17e-10 | 3 | 27 | 3 | 12138202 | |
| Pubmed | Structure and chromosomal locations of mouse steroid receptor coactivator gene family. | 4.17e-10 | 3 | 27 | 3 | 10501088 | |
| Pubmed | The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. | 4.17e-10 | 3 | 27 | 3 | 16423883 | |
| Pubmed | 6.81e-10 | 17 | 27 | 4 | 19183483 | ||
| Pubmed | 7.76e-10 | 57 | 27 | 5 | 18022353 | ||
| Pubmed | 7.76e-10 | 638 | 27 | 9 | 31182584 | ||
| Pubmed | 1.16e-09 | 268 | 27 | 7 | 33640491 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 26066330 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 18267973 | ||
| Pubmed | Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells. | 1.67e-09 | 4 | 27 | 3 | 15331759 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 19095746 | ||
| Pubmed | Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. | 1.67e-09 | 4 | 27 | 3 | 22560224 | |
| Pubmed | A simple method to screen ligands of peroxisome proliferator-activated receptor delta. | 1.67e-09 | 4 | 27 | 3 | 16930961 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 26267537 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 15563453 | ||
| Pubmed | 1.78e-09 | 285 | 27 | 7 | 34369648 | ||
| Pubmed | 3.87e-09 | 78 | 27 | 5 | 28611094 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 10652338 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 17950690 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 17476305 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 17854779 | ||
| Pubmed | Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes. | 4.17e-09 | 5 | 27 | 3 | 18511550 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 10381882 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 12514218 | ||
| Pubmed | Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. | 4.17e-09 | 5 | 27 | 3 | 11376110 | |
| Pubmed | Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. | 4.17e-09 | 5 | 27 | 3 | 18798693 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 12554772 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 10757795 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 10803578 | ||
| Pubmed | 5.10e-09 | 1103 | 27 | 10 | 34189442 | ||
| Pubmed | 5.82e-09 | 28 | 27 | 4 | 24880616 | ||
| Pubmed | 6.25e-09 | 549 | 27 | 8 | 38280479 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 8.33e-09 | 6 | 27 | 3 | 11076796 | |
| Pubmed | 8.33e-09 | 6 | 27 | 3 | 16373399 | ||
| Pubmed | 8.33e-09 | 6 | 27 | 3 | 12630920 | ||
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 8.33e-09 | 6 | 27 | 3 | 20368990 | |
| Pubmed | 8.33e-09 | 6 | 27 | 3 | 16728408 | ||
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 21195347 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 1.46e-08 | 7 | 27 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 1.46e-08 | 7 | 27 | 3 | 9192892 | |
| Pubmed | Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. | 1.46e-08 | 7 | 27 | 3 | 11117530 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.46e-08 | 7 | 27 | 3 | 9590696 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 11050077 | ||
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 2.33e-08 | 8 | 27 | 3 | 11971985 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 14747462 | ||
| Pubmed | Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. | 2.33e-08 | 8 | 27 | 3 | 12145209 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 23178929 | ||
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 17475621 | ||
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 10490106 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.55e-08 | 954 | 27 | 9 | 36373674 | |
| Pubmed | 3.48e-08 | 43 | 27 | 4 | 26487511 | ||
| Pubmed | EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. | 3.49e-08 | 9 | 27 | 3 | 12538641 | |
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 15184363 | ||
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 11087842 | ||
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 15888456 | ||
| Pubmed | 4.37e-08 | 261 | 27 | 6 | 33277362 | ||
| Pubmed | 4.99e-08 | 10 | 27 | 3 | 17363140 | ||
| Pubmed | 4.99e-08 | 10 | 27 | 3 | 15001550 | ||
| Pubmed | 6.86e-08 | 11 | 27 | 3 | 11704662 | ||
| Pubmed | 6.86e-08 | 11 | 27 | 3 | 16109736 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.86e-08 | 774 | 27 | 8 | 15302935 | |
| Pubmed | 9.14e-08 | 12 | 27 | 3 | 12189208 | ||
| Pubmed | Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. | 1.19e-07 | 13 | 27 | 3 | 19255064 | |
| Pubmed | 1.19e-07 | 13 | 27 | 3 | 11266503 | ||
| Pubmed | 1.23e-07 | 808 | 27 | 8 | 20412781 | ||
| Pubmed | 1.31e-07 | 157 | 27 | 5 | 30186101 | ||
| Pubmed | 1.51e-07 | 14 | 27 | 3 | 12482968 | ||
| Pubmed | 2.32e-07 | 16 | 27 | 3 | 10882104 | ||
| Pubmed | 4.71e-07 | 20 | 27 | 3 | 16957778 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 5.59e-07 | 85 | 27 | 4 | 16051665 | |
| Pubmed | Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney. | 5.80e-07 | 2 | 27 | 2 | 30179902 | |
| Pubmed | Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. | 5.80e-07 | 2 | 27 | 2 | 21220509 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30273195 | ||
| Pubmed | SRC-1 and TIF2 control energy balance between white and brown adipose tissues. | 5.80e-07 | 2 | 27 | 2 | 12507421 | |
| Pubmed | The coactivator SRC-1 is an essential coordinator of hepatic glucose production. | 5.80e-07 | 2 | 27 | 2 | 21109193 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16141356 | ||
| Interaction | SP7 interactions | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 SSBP3 ARID1A SS18 PRPF40A EP300 | 1.59e-15 | 304 | 27 | 12 | int:SP7 |
| Interaction | ETV4 interactions | 2.62e-14 | 69 | 27 | 8 | int:ETV4 | |
| Interaction | CRX interactions | 5.92e-13 | 254 | 27 | 10 | int:CRX | |
| Interaction | TBR1 interactions | 1.54e-12 | 113 | 27 | 8 | int:TBR1 | |
| Interaction | TBXT interactions | 1.91e-12 | 116 | 27 | 8 | int:TBXT | |
| Interaction | EYA4 interactions | 1.80e-11 | 243 | 27 | 9 | int:EYA4 | |
| Interaction | EWSR1 interactions | CSTF2 BCL9L NCOA3 NCOA6 CLINT1 BCL9 SSBP3 ARID1A PSPC1 PNISR PRPF40A SF1 EP300 | 3.14e-11 | 906 | 27 | 13 | int:EWSR1 |
| Interaction | EGR2 interactions | 4.41e-11 | 171 | 27 | 8 | int:EGR2 | |
| Interaction | ALG13 interactions | 7.60e-11 | 183 | 27 | 8 | int:ALG13 | |
| Interaction | TLX3 interactions | 9.00e-11 | 291 | 27 | 9 | int:TLX3 | |
| Interaction | NUP35 interactions | NCOA2 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 ARID1A PSPC1 PRPF40A EP300 | 9.37e-11 | 424 | 27 | 10 | int:NUP35 |
| Interaction | KLF5 interactions | 1.26e-10 | 195 | 27 | 8 | int:KLF5 | |
| Interaction | PAX9 interactions | 3.15e-10 | 130 | 27 | 7 | int:PAX9 | |
| Interaction | ERG interactions | 3.67e-10 | 223 | 27 | 8 | int:ERG | |
| Interaction | NCOA1 interactions | 7.13e-10 | 146 | 27 | 7 | int:NCOA1 | |
| Interaction | TLE3 interactions | 8.68e-10 | 376 | 27 | 9 | int:TLE3 | |
| Interaction | WWTR1 interactions | 2.39e-09 | 422 | 27 | 9 | int:WWTR1 | |
| Interaction | TLX1 interactions | 2.53e-09 | 175 | 27 | 7 | int:TLX1 | |
| Interaction | SOX17 interactions | 2.56e-09 | 95 | 27 | 6 | int:SOX17 | |
| Interaction | SMARCE1 interactions | 2.69e-09 | 287 | 27 | 8 | int:SMARCE1 | |
| Interaction | NR1I2 interactions | 4.80e-09 | 48 | 27 | 5 | int:NR1I2 | |
| Interaction | MYOD1 interactions | 5.19e-09 | 194 | 27 | 7 | int:MYOD1 | |
| Interaction | FOS interactions | 5.19e-09 | 312 | 27 | 8 | int:FOS | |
| Interaction | GATA2 interactions | 6.19e-09 | 199 | 27 | 7 | int:GATA2 | |
| Interaction | PAX8 interactions | 6.56e-09 | 111 | 27 | 6 | int:PAX8 | |
| Interaction | EP300 interactions | NCOA2 NCOA1 NCOA3 NCOA6 CLINT1 ARID1A PSPC1 SS18 LEF1 PRPF40A SF1 EP300 TP63 | 6.70e-09 | 1401 | 27 | 13 | int:EP300 |
| Interaction | FEV interactions | 7.10e-09 | 203 | 27 | 7 | int:FEV | |
| Interaction | ETS1 interactions | 1.10e-08 | 121 | 27 | 6 | int:ETS1 | |
| Interaction | PAX7 interactions | 1.28e-08 | 124 | 27 | 6 | int:PAX7 | |
| Interaction | RARA interactions | 1.36e-08 | 223 | 27 | 7 | int:RARA | |
| Interaction | AR interactions | NCOA2 NCOA1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 ARID1A PSPC1 PRPF40A EP300 | 2.45e-08 | 992 | 27 | 11 | int:AR |
| Interaction | SOX15 interactions | 2.76e-08 | 141 | 27 | 6 | int:SOX15 | |
| Interaction | GCM1 interactions | 2.87e-08 | 68 | 27 | 5 | int:GCM1 | |
| Interaction | HNF4A interactions | 5.74e-08 | 275 | 27 | 7 | int:HNF4A | |
| Interaction | SOX7 interactions | 7.42e-08 | 82 | 27 | 5 | int:SOX7 | |
| Interaction | PGR interactions | 8.38e-08 | 84 | 27 | 5 | int:PGR | |
| Interaction | SMAD3 interactions | 8.44e-08 | 447 | 27 | 8 | int:SMAD3 | |
| Interaction | IRF4 interactions | 8.89e-08 | 85 | 27 | 5 | int:IRF4 | |
| Interaction | SOX2 interactions | NCOA2 BCL9L NCOA3 NCOA6 CLINT1 BCL9 SSBP3 ARID1A KAT6B SS18 EP300 TP63 | 9.33e-08 | 1422 | 27 | 12 | int:SOX2 |
| Interaction | PPARA interactions | 1.32e-07 | 92 | 27 | 5 | int:PPARA | |
| Interaction | SOX10 interactions | 1.32e-07 | 92 | 27 | 5 | int:SOX10 | |
| Interaction | NFIA interactions | 1.53e-07 | 188 | 27 | 6 | int:NFIA | |
| Interaction | SMG7 interactions | 1.58e-07 | 319 | 27 | 7 | int:SMG7 | |
| Interaction | SOX9 interactions | 1.73e-07 | 97 | 27 | 5 | int:SOX9 | |
| Interaction | SS18L1 interactions | 1.82e-07 | 98 | 27 | 5 | int:SS18L1 | |
| Interaction | THRA interactions | 3.39e-07 | 111 | 27 | 5 | int:THRA | |
| Interaction | RARB interactions | 4.01e-07 | 46 | 27 | 4 | int:RARB | |
| Interaction | ORC6 interactions | 5.19e-07 | 49 | 27 | 4 | int:ORC6 | |
| Interaction | AP1B1 interactions | 5.98e-07 | 237 | 27 | 6 | int:AP1B1 | |
| Interaction | VDR interactions | 6.63e-07 | 127 | 27 | 5 | int:VDR | |
| Interaction | RARG interactions | 1.03e-06 | 58 | 27 | 4 | int:RARG | |
| Interaction | NR1H3 interactions | 1.03e-06 | 58 | 27 | 4 | int:NR1H3 | |
| Interaction | SSBP4 interactions | 1.11e-06 | 59 | 27 | 4 | int:SSBP4 | |
| Interaction | NCOA2 interactions | 1.11e-06 | 141 | 27 | 5 | int:NCOA2 | |
| Interaction | NCOA6 interactions | 1.28e-06 | 145 | 27 | 5 | int:NCOA6 | |
| Interaction | ATG9A interactions | 1.48e-06 | 445 | 27 | 7 | int:ATG9A | |
| Interaction | NR1H2 interactions | 1.96e-06 | 68 | 27 | 4 | int:NR1H2 | |
| Interaction | JUN interactions | 2.13e-06 | 470 | 27 | 7 | int:JUN | |
| Interaction | ASCC1 interactions | 2.33e-06 | 71 | 27 | 4 | int:ASCC1 | |
| Interaction | LHX4 interactions | 2.49e-06 | 166 | 27 | 5 | int:LHX4 | |
| Interaction | CEBPA interactions | 2.50e-06 | 1245 | 27 | 10 | int:CEBPA | |
| Interaction | NFKB1 interactions | 2.69e-06 | 307 | 27 | 6 | int:NFKB1 | |
| Interaction | RXRA interactions | 2.72e-06 | 169 | 27 | 5 | int:RXRA | |
| Interaction | NR3C1 interactions | 2.95e-06 | 974 | 27 | 9 | int:NR3C1 | |
| Interaction | TEAD1 interactions | 3.32e-06 | 176 | 27 | 5 | int:TEAD1 | |
| Interaction | SMC5 interactions | 3.67e-06 | 1000 | 27 | 9 | int:SMC5 | |
| Interaction | RUNX1 interactions | 3.67e-06 | 324 | 27 | 6 | int:RUNX1 | |
| Interaction | CARM1 interactions | 3.74e-06 | 325 | 27 | 6 | int:CARM1 | |
| Interaction | LHX2 interactions | 4.01e-06 | 183 | 27 | 5 | int:LHX2 | |
| Interaction | PPARGC1A interactions | 4.16e-06 | 82 | 27 | 4 | int:PPARGC1A | |
| Interaction | CLTB interactions | 4.23e-06 | 185 | 27 | 5 | int:CLTB | |
| Interaction | THRB interactions | 4.34e-06 | 186 | 27 | 5 | int:THRB | |
| Interaction | GATA3 interactions | 4.46e-06 | 187 | 27 | 5 | int:GATA3 | |
| Interaction | FUS interactions | 4.49e-06 | 757 | 27 | 8 | int:FUS | |
| Interaction | HNF1B interactions | 4.82e-06 | 190 | 27 | 5 | int:HNF1B | |
| Interaction | TLE6 interactions | 4.84e-06 | 25 | 27 | 3 | int:TLE6 | |
| Interaction | GSC interactions | 5.27e-06 | 87 | 27 | 4 | int:GSC | |
| Interaction | STAT6 interactions | 5.27e-06 | 87 | 27 | 4 | int:STAT6 | |
| Interaction | SMARCC2 interactions | 6.00e-06 | 353 | 27 | 6 | int:SMARCC2 | |
| Interaction | FOXI1 interactions | 6.59e-06 | 92 | 27 | 4 | int:FOXI1 | |
| Interaction | PYGO1 interactions | 6.87e-06 | 28 | 27 | 3 | int:PYGO1 | |
| Interaction | PIAS3 interactions | 7.48e-06 | 95 | 27 | 4 | int:PIAS3 | |
| Interaction | ETV1 interactions | 7.66e-06 | 29 | 27 | 3 | int:ETV1 | |
| Interaction | AP2B1 interactions | 8.23e-06 | 373 | 27 | 6 | int:AP2B1 | |
| Interaction | SMARCC1 interactions | 9.71e-06 | 384 | 27 | 6 | int:SMARCC1 | |
| Interaction | SMAD2 interactions | 9.85e-06 | 385 | 27 | 6 | int:SMAD2 | |
| Interaction | NR1H4 interactions | 1.04e-05 | 32 | 27 | 3 | int:NR1H4 | |
| Interaction | CREBBP interactions | 1.05e-05 | 599 | 27 | 7 | int:CREBBP | |
| Interaction | SSBP2 interactions | 1.11e-05 | 105 | 27 | 4 | int:SSBP2 | |
| Interaction | WBP4 interactions | 1.29e-05 | 109 | 27 | 4 | int:WBP4 | |
| Interaction | LDB1 interactions | 1.60e-05 | 115 | 27 | 4 | int:LDB1 | |
| Interaction | PPARD interactions | 1.71e-05 | 117 | 27 | 4 | int:PPARD | |
| Interaction | RORA interactions | 1.90e-05 | 39 | 27 | 3 | int:RORA | |
| Interaction | PML interactions | 2.07e-05 | 933 | 27 | 8 | int:PML | |
| Interaction | NR5A2 interactions | 2.21e-05 | 41 | 27 | 3 | int:NR5A2 | |
| Interaction | ISL1 interactions | 2.21e-05 | 41 | 27 | 3 | int:ISL1 | |
| Interaction | ISL2 interactions | 2.21e-05 | 41 | 27 | 3 | int:ISL2 | |
| Interaction | BRCA1 interactions | 2.22e-05 | 1249 | 27 | 9 | int:BRCA1 | |
| Interaction | RUNX2 interactions | 2.29e-05 | 126 | 27 | 4 | int:RUNX2 | |
| Interaction | TNIP2 interactions | 2.39e-05 | 952 | 27 | 8 | int:TNIP2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 3.48e-03 | 149 | 27 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 6.66e-03 | 208 | 27 | 2 | chr10q22 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.66e-13 | 17 | 14 | 5 | 486 | |
| GeneFamily | Basic helix-loop-helix proteins | 7.60e-05 | 110 | 14 | 3 | 420 | |
| GeneFamily | ArfGAPs | 2.90e-04 | 33 | 14 | 2 | 395 | |
| GeneFamily | RNA binding motif containing | 1.15e-02 | 213 | 14 | 2 | 725 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA1 NCOA3 SYNRG ARID1A KAT6B PNISR SMAP2 PRPF40A SF1 EP300 ITSN2 | 1.10e-07 | 1492 | 27 | 11 | M40023 |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 4.59e-07 | 294 | 27 | 6 | M40873 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 5.17e-07 | 300 | 27 | 6 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.60e-06 | 856 | 27 | 8 | M4500 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP | 1.73e-06 | 200 | 27 | 5 | M9447 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 1.73e-06 | 200 | 27 | 5 | M5991 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_DN | 1.73e-06 | 200 | 27 | 5 | M3355 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP | 1.73e-06 | 200 | 27 | 5 | M3648 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 4.11e-06 | 429 | 27 | 6 | M29 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 6.59e-06 | 466 | 27 | 6 | M13522 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.43e-05 | 145 | 27 | 4 | M1810 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.49e-05 | 822 | 27 | 7 | M6782 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.78e-05 | 323 | 27 | 5 | M9150 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 2.49e-05 | 167 | 27 | 4 | M365 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 3.11e-05 | 363 | 27 | 5 | M41103 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 4.29e-05 | 192 | 27 | 4 | M2317 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 4.33e-05 | 389 | 27 | 5 | M6520 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 4.47e-05 | 194 | 27 | 4 | MM910 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 4.93e-05 | 199 | 27 | 4 | M7254 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 4.93e-05 | 199 | 27 | 4 | M5970 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 4.93e-05 | 199 | 27 | 4 | M7374 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 5.03e-05 | 200 | 27 | 4 | M9472 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 5.03e-05 | 200 | 27 | 4 | M8026 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 5.03e-05 | 200 | 27 | 4 | M387 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 5.03e-05 | 200 | 27 | 4 | M5851 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 5.03e-05 | 200 | 27 | 4 | M7908 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_UP | 5.03e-05 | 200 | 27 | 4 | M5174 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 7.81e-05 | 224 | 27 | 4 | M2500 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP | 1.80e-04 | 107 | 27 | 3 | M7141 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | 2.00e-04 | 1239 | 27 | 7 | M1743 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 2.08e-04 | 289 | 27 | 4 | M13630 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | 2.41e-04 | 1277 | 27 | 7 | MM1032 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 2.92e-04 | 316 | 27 | 4 | M2248 | |
| Coexpression | EPPERT_HSC_R | 2.98e-04 | 127 | 27 | 3 | M19231 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 3.07e-04 | 320 | 27 | 4 | MM1063 | |
| Coexpression | AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS | 3.49e-04 | 134 | 27 | 3 | M39133 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | 3.94e-04 | 342 | 27 | 4 | M41062 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 4.23e-04 | 634 | 27 | 5 | M40866 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 4.74e-04 | 1009 | 27 | 6 | M157 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 5.05e-04 | 152 | 27 | 3 | M39239 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 5.12e-04 | 1024 | 27 | 6 | M1742 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 5.86e-04 | 160 | 27 | 3 | M11011 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 5.95e-04 | 35 | 27 | 2 | M13814 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_DN | 6.30e-04 | 164 | 27 | 3 | M10311 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 6.52e-04 | 1072 | 27 | 6 | MM1031 | |
| Coexpression | GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN | 6.53e-04 | 166 | 27 | 3 | M8182 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 6.85e-04 | 705 | 27 | 5 | M1410 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 6.97e-04 | 398 | 27 | 4 | M14877 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP | 7.48e-04 | 174 | 27 | 3 | M8885 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | 7.82e-04 | 726 | 27 | 5 | M4210 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL | 7.93e-04 | 412 | 27 | 4 | M45729 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 8.38e-04 | 181 | 27 | 3 | M8662 | |
| Coexpression | ZHAN_EARLY_DIFFERENTIATION_GENES_DN | 8.58e-04 | 42 | 27 | 2 | M1476 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 8.66e-04 | 183 | 27 | 3 | M8189 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 8.79e-04 | 184 | 27 | 3 | M19988 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP | 9.79e-04 | 191 | 27 | 3 | M8251 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | 9.94e-04 | 192 | 27 | 3 | M7571 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | 9.95e-04 | 438 | 27 | 4 | M227 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 1.01e-03 | 193 | 27 | 3 | M6730 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP | 1.01e-03 | 193 | 27 | 3 | M7464 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | 1.06e-03 | 196 | 27 | 3 | M4532 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_UP | 1.07e-03 | 197 | 27 | 3 | M3345 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN | 1.07e-03 | 197 | 27 | 3 | M5877 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 1.09e-03 | 198 | 27 | 3 | M7480 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 1.09e-03 | 198 | 27 | 3 | M4478 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_UP | 1.10e-03 | 199 | 27 | 3 | M3703 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP | 1.10e-03 | 199 | 27 | 3 | M3639 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 1.10e-03 | 199 | 27 | 3 | M4526 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP | 1.10e-03 | 199 | 27 | 3 | M8324 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 1.10e-03 | 199 | 27 | 3 | M5726 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN | 1.10e-03 | 199 | 27 | 3 | M3554 | |
| Coexpression | GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP | 1.10e-03 | 199 | 27 | 3 | M5753 | |
| Coexpression | GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP | 1.10e-03 | 199 | 27 | 3 | M3046 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | 1.10e-03 | 199 | 27 | 3 | M4331 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 1.12e-03 | 200 | 27 | 3 | M9490 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.12e-03 | 200 | 27 | 3 | M9889 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP | 1.12e-03 | 200 | 27 | 3 | M8567 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.12e-03 | 200 | 27 | 3 | M9449 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 1.12e-03 | 200 | 27 | 3 | M7256 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 1.12e-03 | 200 | 27 | 3 | M3374 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 1.12e-03 | 200 | 27 | 3 | M6426 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_DN | 1.12e-03 | 200 | 27 | 3 | M5963 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN | 1.12e-03 | 200 | 27 | 3 | M3779 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN | 1.12e-03 | 200 | 27 | 3 | M3628 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP | 1.12e-03 | 200 | 27 | 3 | M3614 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN | 1.12e-03 | 200 | 27 | 3 | M3646 | |
| Coexpression | GSE17721_12H_VS_24H_LPS_BMDC_UP | 1.12e-03 | 200 | 27 | 3 | M4081 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_UP | 1.12e-03 | 200 | 27 | 3 | M4119 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 1.12e-03 | 200 | 27 | 3 | M4108 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | 1.12e-03 | 200 | 27 | 3 | M9842 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN | 1.12e-03 | 200 | 27 | 3 | M3965 | |
| Coexpression | GSE10325_BCELL_VS_LUPUS_BCELL_DN | 1.12e-03 | 200 | 27 | 3 | M3095 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN | 1.12e-03 | 200 | 27 | 3 | M8331 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 1.12e-03 | 200 | 27 | 3 | M7502 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | 1.12e-03 | 200 | 27 | 3 | M7900 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_UP | 1.12e-03 | 200 | 27 | 3 | M5743 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.12e-03 | 200 | 27 | 3 | M4456 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 1.12e-03 | 200 | 27 | 3 | M3877 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 1.12e-03 | 200 | 27 | 3 | M6044 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 1.12e-03 | 200 | 27 | 3 | M4352 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.68e-06 | 298 | 27 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.08e-06 | 105 | 27 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | 2.01e-05 | 979 | 27 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 1.18e-04 | 390 | 27 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.42e-04 | 406 | 27 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.54e-04 | 413 | 27 | 5 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 1.63e-04 | 84 | 27 | 3 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 2.68e-04 | 1414 | 27 | 8 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 2.79e-04 | 1060 | 27 | 7 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.86e-04 | 744 | 27 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.04e-04 | 259 | 27 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 3.32e-04 | 1459 | 27 | 8 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 3.41e-04 | 769 | 27 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.66e-04 | 498 | 27 | 5 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.68e-04 | 780 | 27 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.31e-04 | 284 | 27 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 4.38e-04 | 806 | 27 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 5.56e-04 | 843 | 27 | 6 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.07e-04 | 311 | 27 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 7.62e-04 | 1252 | 27 | 7 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 7.80e-04 | 1257 | 27 | 7 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 182 | 27 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 185 | 27 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.40e-04 | 168 | 27 | 3 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.40e-04 | 168 | 27 | 3 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 169 | 27 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.48e-04 | 171 | 27 | 3 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.48e-04 | 171 | 27 | 3 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-04 | 174 | 27 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 176 | 27 | 3 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 176 | 27 | 3 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 179 | 27 | 3 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 179 | 27 | 3 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 179 | 27 | 3 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.86e-04 | 185 | 27 | 3 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.89e-04 | 186 | 27 | 3 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.89e-04 | 186 | 27 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-04 | 188 | 27 | 3 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-04 | 191 | 27 | 3 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | 348d39da3016dc6dbfa65d108e5def35aa7f19dd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 193 | 27 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.11e-04 | 193 | 27 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.14e-04 | 194 | 27 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-04 | 194 | 27 | 3 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-04 | 195 | 27 | 3 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.17e-04 | 195 | 27 | 3 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-04 | 195 | 27 | 3 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 2.17e-04 | 195 | 27 | 3 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 196 | 27 | 3 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.20e-04 | 196 | 27 | 3 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Mild/Remission-B_naive-2|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.24e-04 | 197 | 27 | 3 | 0042716ba630e4d5142cca46fcb279a2e64370f2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 197 | 27 | 3 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-04 | 197 | 27 | 3 | 9f0d91bb7aec4f2442259eca1ddf7905f8d40e9b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 2.24e-04 | 197 | 27 | 3 | 07f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.24e-04 | 197 | 27 | 3 | bf80e39cd68fd5bb85c8726d4f82648391de74ad | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-04 | 197 | 27 | 3 | 296b27348ca7e9acf746f752cf810e4e5baea76c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-04 | 197 | 27 | 3 | 258dfe69b5faeaee709422f873b144ca5e4a6452 | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.24e-04 | 197 | 27 | 3 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-04 | 198 | 27 | 3 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-04 | 198 | 27 | 3 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | Severe-B_memory-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.27e-04 | 198 | 27 | 3 | 9cc75d14f1220fe15e530115f6dff09c31f07f7c | |
| ToppCell | Mild/Remission-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.27e-04 | 198 | 27 | 3 | d238ad320e1989da01c48587f79eaeaa469cfa28 | |
| ToppCell | Severe-B_memory-3|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.27e-04 | 198 | 27 | 3 | a3050c126799e32f742a14396236572250476820 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.31e-04 | 199 | 27 | 3 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 199 | 27 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.31e-04 | 199 | 27 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.31e-04 | 199 | 27 | 3 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Severe / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 1fb96090b5205e95ec21378bf4b88eec7257cf7e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 3.38e-04 | 45 | 27 | 2 | 5488dced1d338166f3021509ebe8673e03995978 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.95e-10 | 170 | 27 | 7 | 1050_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.19e-09 | 177 | 27 | 7 | 1645_DN | |
| Drug | butamben | 2.97e-08 | 6 | 27 | 3 | ctd:C004605 | |
| Drug | glutamin | 4.21e-08 | 461 | 27 | 8 | CID000000738 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.42e-08 | 172 | 27 | 6 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.73e-08 | 174 | 27 | 6 | 1659_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.90e-08 | 175 | 27 | 6 | 1014_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.07e-08 | 176 | 27 | 6 | 6932_DN | |
| Drug | AC1L2E0P | 5.33e-08 | 307 | 27 | 7 | CID000019390 | |
| Drug | 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 | 2.44e-07 | 11 | 27 | 3 | ctd:C061137 | |
| Drug | dihydroxy-vitamin D3 | 4.22e-07 | 13 | 27 | 3 | ctd:C118756 | |
| Drug | ferutinin | 8.24e-07 | 16 | 27 | 3 | CID000354654 | |
| Drug | iclaprim | 8.35e-07 | 62 | 27 | 4 | CID000213043 | |
| Drug | B on A | 8.71e-07 | 464 | 27 | 7 | CID000007104 | |
| Drug | galangin | 1.21e-06 | 68 | 27 | 4 | ctd:C037032 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.33e-06 | 165 | 27 | 5 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.46e-06 | 168 | 27 | 5 | 3868_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.50e-06 | 169 | 27 | 5 | 5231_DN | |
| Drug | In-G | 1.55e-06 | 170 | 27 | 5 | CID000446054 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.59e-06 | 171 | 27 | 5 | 7535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.69e-06 | 173 | 27 | 5 | 5950_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.69e-06 | 173 | 27 | 5 | 3243_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.73e-06 | 174 | 27 | 5 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.73e-06 | 174 | 27 | 5 | 5065_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.78e-06 | 175 | 27 | 5 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.83e-06 | 176 | 27 | 5 | 7499_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.89e-06 | 177 | 27 | 5 | 6434_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.89e-06 | 177 | 27 | 5 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.94e-06 | 178 | 27 | 5 | 7245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.94e-06 | 178 | 27 | 5 | 1672_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.05e-06 | 180 | 27 | 5 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.05e-06 | 180 | 27 | 5 | 6886_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.05e-06 | 180 | 27 | 5 | 4541_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.05e-06 | 180 | 27 | 5 | 4821_DN | |
| Drug | cystamine | 2.10e-06 | 181 | 27 | 5 | CID000002915 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.10e-06 | 181 | 27 | 5 | 6951_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 2.10e-06 | 181 | 27 | 5 | 1791_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.16e-06 | 182 | 27 | 5 | 1951_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.54e-06 | 188 | 27 | 5 | 6735_DN | |
| Drug | AC1L1COZ | 3.74e-06 | 90 | 27 | 4 | CID000001996 | |
| Drug | androstenol | 4.27e-06 | 27 | 27 | 3 | CID000101989 | |
| Drug | TCPOBOP | 4.64e-06 | 95 | 27 | 4 | CID000005382 | |
| Drug | AC1L22FJ | 4.67e-06 | 213 | 27 | 5 | CID000013766 | |
| Drug | CV-1 | 4.67e-06 | 213 | 27 | 5 | CID000130105 | |
| Drug | 3-hydroxyflavone | 5.32e-06 | 29 | 27 | 3 | ctd:C041477 | |
| Drug | anacardic acid | 5.91e-06 | 30 | 27 | 3 | CID000167551 | |
| Drug | hydroxyflutamide | 6.40e-06 | 103 | 27 | 4 | CID000091649 | |
| Drug | DHBT | 1.13e-05 | 119 | 27 | 4 | CID000001855 | |
| Drug | AC1ND2OB | 1.35e-05 | 265 | 27 | 5 | CID004568637 | |
| Drug | 2',3',4',5'-tetrachloro-4-biphenylol | 2.03e-05 | 6 | 27 | 2 | ctd:C104006 | |
| Drug | androstan-3-ol | 2.03e-05 | 6 | 27 | 2 | ctd:C000658 | |
| Drug | Androstenedione | 2.04e-05 | 45 | 27 | 3 | ctd:D000735 | |
| Drug | AC1L1G5B | 2.18e-05 | 46 | 27 | 3 | CID000003531 | |
| Drug | vorinostat | 3.04e-05 | 314 | 27 | 5 | CID000005311 | |
| Drug | 5 alpha-dihydrotestosterone | 3.48e-05 | 323 | 27 | 5 | CID000000015 | |
| Drug | tris(chloroethyl)phosphate | 3.74e-05 | 55 | 27 | 3 | ctd:C031324 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.91e-05 | 163 | 27 | 4 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.91e-05 | 163 | 27 | 4 | 7453_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.10e-05 | 165 | 27 | 4 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.10e-05 | 165 | 27 | 4 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.20e-05 | 166 | 27 | 4 | 2247_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.20e-05 | 166 | 27 | 4 | 7324_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 4.30e-05 | 167 | 27 | 4 | 5217_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.50e-05 | 169 | 27 | 4 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.50e-05 | 169 | 27 | 4 | 6064_DN | |
| Drug | glycine | 4.50e-05 | 169 | 27 | 4 | CID000000750 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.60e-05 | 170 | 27 | 4 | 5417_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.60e-05 | 170 | 27 | 4 | 7043_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.71e-05 | 171 | 27 | 4 | 1000_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.71e-05 | 171 | 27 | 4 | 5441_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.82e-05 | 172 | 27 | 4 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.82e-05 | 172 | 27 | 4 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.82e-05 | 172 | 27 | 4 | 2794_DN | |
| Drug | 2-acetyltributylcitrate | 4.85e-05 | 9 | 27 | 2 | ctd:C014953 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.93e-05 | 173 | 27 | 4 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.93e-05 | 173 | 27 | 4 | 4237_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.93e-05 | 173 | 27 | 4 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.93e-05 | 173 | 27 | 4 | 5987_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.93e-05 | 173 | 27 | 4 | 5336_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.04e-05 | 174 | 27 | 4 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.04e-05 | 174 | 27 | 4 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.04e-05 | 174 | 27 | 4 | 3462_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.04e-05 | 174 | 27 | 4 | 5693_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.04e-05 | 174 | 27 | 4 | 5580_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.15e-05 | 175 | 27 | 4 | 6316_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.15e-05 | 175 | 27 | 4 | 5935_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.15e-05 | 175 | 27 | 4 | 6736_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.15e-05 | 175 | 27 | 4 | 3787_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.15e-05 | 175 | 27 | 4 | 6891_DN | |
| Drug | 2,6-dihydroxybenzoic acid | 5.15e-05 | 175 | 27 | 4 | CID000009338 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.27e-05 | 176 | 27 | 4 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.27e-05 | 176 | 27 | 4 | 981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.27e-05 | 176 | 27 | 4 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.27e-05 | 176 | 27 | 4 | 1535_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.39e-05 | 177 | 27 | 4 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.39e-05 | 177 | 27 | 4 | 6340_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.39e-05 | 177 | 27 | 4 | 6972_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.39e-05 | 177 | 27 | 4 | 5308_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.39e-05 | 177 | 27 | 4 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.51e-05 | 178 | 27 | 4 | 1471_DN | |
| Disease | Malignant neoplasm of breast | NCOA2 NCOA1 NCOA3 NCOA6 ZMIZ1 ARID1A KAT6B LEF1 EP300 MEIS1 ITSN2 | 1.08e-09 | 1074 | 27 | 11 | C0006142 |
| Disease | Breast Carcinoma | 1.90e-08 | 538 | 27 | 8 | C0678222 | |
| Disease | prostate cancer (is_marker_for) | 2.85e-07 | 156 | 27 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Mammary Neoplasms, Human | 3.54e-07 | 525 | 27 | 7 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 3.54e-07 | 525 | 27 | 7 | C4704874 | |
| Disease | Mammary Neoplasms | 3.63e-07 | 527 | 27 | 7 | C1458155 | |
| Disease | breast carcinoma (is_marker_for) | 3.01e-05 | 66 | 27 | 3 | DOID:3459 (is_marker_for) | |
| Disease | diffuse large B-cell lymphoma | 7.29e-05 | 14 | 27 | 2 | EFO_0000403 | |
| Disease | T-Cell Lymphoma | 9.60e-05 | 16 | 27 | 2 | C0079772 | |
| Disease | electrocardiography | 1.07e-04 | 530 | 27 | 5 | EFO_0004327 | |
| Disease | Colorectal Neoplasms | 1.13e-04 | 277 | 27 | 4 | C0009404 | |
| Disease | Adenocarcinoma | 1.62e-04 | 116 | 27 | 3 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 1.62e-04 | 116 | 27 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.62e-04 | 116 | 27 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.62e-04 | 116 | 27 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.62e-04 | 116 | 27 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.62e-04 | 116 | 27 | 3 | C0205641 | |
| Disease | fat intake measurement | 1.84e-04 | 22 | 27 | 2 | EFO_0010809 | |
| Disease | Squamous cell carcinoma | 1.97e-04 | 124 | 27 | 3 | C0007137 | |
| Disease | puberty onset measurement | 2.02e-04 | 125 | 27 | 3 | EFO_0005677 | |
| Disease | Prostatic Neoplasms | 2.15e-04 | 616 | 27 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.15e-04 | 616 | 27 | 5 | C0376358 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 3.00e-04 | 28 | 27 | 2 | DOID:8634 (is_marker_for) | |
| Disease | breast cancer (is_implicated_in) | 3.44e-04 | 150 | 27 | 3 | DOID:1612 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 3.93e-04 | 702 | 27 | 5 | C0009402 | |
| Disease | hippocampus molecular layer volume | 4.71e-04 | 35 | 27 | 2 | EFO_0009397 | |
| Disease | colon cancer (is_implicated_in) | 4.98e-04 | 36 | 27 | 2 | DOID:219 (is_implicated_in) | |
| Disease | platelet component distribution width | 5.47e-04 | 755 | 27 | 5 | EFO_0007984 | |
| Disease | hippocampal CA4 volume | 6.47e-04 | 41 | 27 | 2 | EFO_0009396 | |
| Disease | Breast adenocarcinoma | 6.47e-04 | 41 | 27 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.47e-04 | 41 | 27 | 2 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 6.47e-04 | 41 | 27 | 2 | C0007138 | |
| Disease | candidiasis (implicated_via_orthology) | 7.45e-04 | 44 | 27 | 2 | DOID:1508 (implicated_via_orthology) | |
| Disease | testosterone measurement | 8.71e-04 | 1275 | 27 | 6 | EFO_0004908 | |
| Disease | disease recurrence, colon carcinoma | 1.00e-03 | 51 | 27 | 2 | EFO_0004952, EFO_1001950 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGMMNSPVNQPAMGM | 151 | Q09472 | |
| PAMGMNTGMNAGMNP | 161 | Q09472 | |
| NTGMNAGMNPGMLAA | 166 | Q09472 | |
| QGMRPMSNMSASPMG | 501 | Q09472 | |
| PPMGGMSPQAQQMNM | 2156 | Q09472 | |
| GTGMPMMPQQPVMFA | 846 | O60641 | |
| MQASMQGGVPAPGQM | 246 | P33240 | |
| MMAQFPTAMNGGPNM | 1 | Q9NZM3 | |
| TPQYPMQMQMGMMGT | 2016 | Q8WYB5 | |
| MMPNMNNDPYMSNGS | 116 | Q9UJU2 | |
| MGIRAPGPMSGMGMN | 366 | O00470 | |
| PGPMSGMGMNMGMEG | 371 | O00470 | |
| NMANMPPQVGSGMCP | 871 | O14497 | |
| MGMAPLGNTPMMNQS | 561 | Q14677 | |
| PMGQMPGMMSSVMPG | 96 | O75400 | |
| MMAPHNQMMGPQGQV | 691 | Q14686 | |
| PDGMGANIPMMGTHM | 496 | Q9H3D4 | |
| HPGPVGSPGMMMSMQ | 1371 | O00512 | |
| HPPGGDMGQQMNMMI | 491 | Q86UU0 | |
| GPGNLNMNMNVNMNM | 766 | Q86UU0 | |
| AQGTGGPPQNSMMMA | 1191 | Q86UU0 | |
| PMNMMQVMSEGGPQP | 1096 | Q5VU65 | |
| MGGSMQRMNPPRGMG | 196 | Q9BWW4 | |
| PMVSVMQPNMQGIMG | 51 | Q9UMZ2 | |
| MAGGNTNVQNMNPMM | 1321 | Q15788 | |
| NGSSGHMGQMNMNPM | 1396 | Q9Y6Q9 | |
| QPGMMGNQGMIGNQG | 916 | Q15596 | |
| APMAMPAGYMGGMQA | 331 | Q8WU79 | |
| GGMQASMMGVPNGMM | 341 | Q8WU79 | |
| QGPPPMMGMNMNNRA | 416 | Q8WXF1 | |
| MMGMNMNNRATIPGP | 421 | Q8WXF1 | |
| GGQHYQGQQPPMGMM | 221 | Q15532 | |
| GQSPSMMVGMPMPNG | 361 | Q8IYB5 | |
| MMVGMPMPNGFMGNA | 366 | Q8IYB5 | |
| PMPNGFMGNAQTGVM | 371 | Q8IYB5 | |
| QPPGMMPNGQDMSTM | 56 | Q8TF01 | |
| NFVTMMGMGVAGMPP | 611 | Q15637 | |
| NPMNPGGNPMASGMT | 191 | Q9ULJ6 | |
| SMGGSMNPASMAAGM | 341 | Q9ULJ6 | |
| MNPASMAAGMTPSGM | 346 | Q9ULJ6 |